CD79A and COVID-19: Sinnberg et al. demonstrated that IgA autoantibodies to pulmonary surfactant proteins B and C are detectable in patients with COVID-19 and that these autoantibodies impair the ability of pulmonary surfactant to decrease surface tension (56).